Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
复制标题
异常 mRNA 剪接的矫正器可恢复家族性自主神经功能障碍中的 tRNA 修饰。
DOI:
10.1073/pnas.1415525112
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Hagiwara M.
中科院分区:
文献类型:
--
作者:
Yoshida M;Kataoka N;Miyauchi K;Ohe K;Iida K;Yoshida S;Nojima T;Okuno Y;Onogi H;Usui T;Takeuchi A;Hosoya T;Suzuki T;Hagiwara M.
Familial dysautonomia (FD), a hereditary sensory and autonomic neuropathy, is caused by missplicing of exon 20, resulting from an intronic mutation in the inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein (IKBKAP) gene encoding IKK complex-associated protein (IKAP)/elongator protein 1 (ELP1). A newly established splicing reporter assay allowed us to visualize pathogenic splicing in cells and to screen small chemicals for the ability to correct the aberrant splicing ofIKBKAP. Using this splicing reporter, we screened our chemical libraries and identified a compound, rectifier of aberrant splicing (RECTAS), that rectifies the aberrantIKBKAPsplicing in cells from patients with FD. Here, we found that the levels of modified uridine at the wobble position in cytoplasmic tRNAs are reduced in cells from patients with FD and that treatment with RECTAS increases the expression of IKAP and recovers the tRNA modifications. These findings suggest that the missplicing ofIKBKAPresults in reduced tRNA modifications in patients with FD and that RECTAS is a promising therapeutic drug candidate for FD.